Related Experiment Video
Updated: Aug 21, 2026

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
Published on: March 12, 2018
[How to assess coronary lesion, reperfusion quality, and PCI result?]
1Centre cardiologique du Nord, 32, rue des Moulins-Gémeaux, 93200 Saint-Denis, France. olivier.barthelemy@psl.ap-hop-paris.fr
Insights
Assessing cardiac ischemia requires more than just coronary angiograms. Ischemia-driven decisions and advanced tools are crucial for evaluating reperfusion quality and angioplasty outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Imaging
Context:
- Discussions at the High Tech congress 2004 highlighted limitations in assessing cardiac ischemia, reperfusion, and angioplasty outcomes.
- Current methods like coronary angiography are insufficient for determining optimal therapeutic strategies.
- There is a need for improved diagnostic tools and criteria.
Purpose:
- To explore accurate methods for assessing the need for ischemia-driven revascularization.
- To identify superior tools for evaluating myocardial reperfusion quality post-angioplasty.
- To define key angiographic and clinical criteria for assessing angioplasty results.
Summary:
- Coronary angiography alone is inadequate for guiding therapeutic decisions in cardiac ischemia.
- Ischemia-driven decision-making offers a superior approach.
- Achieving TIMI 3 flow grade (angiographic success) does not guarantee optimal myocardial reperfusion, necessitating better assessment tools.
Impact:
- Highlights the inadequacy of traditional methods in cardiac ischemia assessment.
- Emphasizes the importance of ischemia-driven strategies for patient care.
- Calls for the adoption of more advanced tools and criteria for precise evaluation of angioplasty outcomes.
Abstract:
During High Tech congress 2004, different questions have been discussed concerning the assessment of cardiac ischemia, quality of reperfusion and result of angioplasty. Coronary angiogram alone is not enough to decide the optimal therapeutic strategy. Ischemia-driven decision is a much better option. How should we assess the more accurately the need for ischemia-driven revascularization? Angiographic success (TIMI 3 flow grade) after angioplasty is near 95%, but is not sufficient to assess precisely the quality of myocardial reperfusion. Which more efficient tools are available? At last, which angiographic or clinical criteria should we use to assess the result of angioplasty?
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease V: Interprofessional Care
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome IV: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

